Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Key findings from this phase 2 obesity trial included: Mean weight reduction of up to approximately 24.2% at the highest dose (12 mg) after 48 weeks Dose-dependent reductions in body weight across all active treatment arms Significant reductions in waist circumference, blood pressure, and lipid parameters Improvements in fasting glucose and insulin resistance markers A separate phase 2 trial in adults with type 2 diabetes (published in 2023) demonstrated meaningful HbA1c reductions alongside substantial weight loss, suggesting potential dual utility in both obesity and glycaemic management
Its worth checking the nutrition label for the specific product youre considering
If constipation persists, ask your clinician about safe OTC options
Personal health history matters more than payment method
Food and Drug Administration (FDA) in 2017 to lower blood sugar and A1C levels for people with type 2 diabetes
